We are live on ! Find out more
TECH icon

Bio-Techne

556 hedge funds and large institutions have $16.2B invested in Bio-Techne in 2022 Q1 according to their latest regulatory filings, with 65 funds opening new positions, 199 increasing their positions, 209 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

269% more call options, than puts

Call options by funds: $30.2M | Put options by funds: $8.18M

8.03% more ownership

Funds ownership: 376.15%384.18% (+8%)

5% less repeat investments, than reductions

Existing positions increased: 199 | Existing positions reduced: 209

3% less funds holding

Funds holding: 575556 (-19)

14% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 76

15% less capital invested

Capital invested by funds: $19.1B → $16.2B (-$2.9B)

20% less funds holding in top 10

Funds holding in top 10: 1512 (-3)

Holders
556
Holders Change
-19
Holders Change %
-3.3%
% of All Funds
8.77%
Holding in Top 10
12
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-20%
% of All Funds
0.19%
New
65
Increased
199
Reduced
209
Closed
76
Calls
$30.2M
Puts
$8.18M
Net Calls
+$22M
Net Calls Change
+$14.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Sands Capital Management
51
Sands Capital Management
Virginia
$71.8M +$28.3M +274,752 +71%
SIMG
52
Stephens Investment Management Group
Texas
$70.9M +$796K +7,720 +1%
JP Morgan Chase
53
JP Morgan Chase
New York
$66.1M -$3.53M -34,168 -5%
Dimensional Fund Advisors
54
Dimensional Fund Advisors
Texas
$65.8M -$463K -4,484 -0.7%
UBS AM
55
UBS AM
Illinois
$62.2M +$1.25M +12,116 +2%
PPA
56
Parametric Portfolio Associates
Washington
$60.5M +$7.96M +77,160 +16%
N
57
Nuveen
North Carolina
$57M +$11.7M +113,368 +28%
Deutsche Bank
58
Deutsche Bank
Germany
$54.7M +$8.7M +84,356 +20%
EAM
59
Eagle Asset Management
Florida
$54.5M +$86.3K +836 +0.2%
SCP
60
Sandhill Capital Partners
New York
$47.6M -$4.85M -46,972 -10%
Morgan Stanley
61
Morgan Stanley
New York
$45.8M +$4.38M +42,444 +11%
OWP
62
Obermeyer Wealth Partners
Colorado
$43.4M +$398K +3,860 +1%
AAP
63
Aristotle Atlantic Partners
Florida
$42M +$589K +5,712 +1%
Wells Fargo
64
Wells Fargo
California
$41.3M +$15.2M +147,504 +63%
MAM
65
Montanaro Asset Management
United Kingdom
$39M -$5.98M -58,000 -14%
Principal Financial Group
66
Principal Financial Group
Iowa
$37.1M -$15.9M -154,224 -31%
California Public Employees Retirement System
67
California Public Employees Retirement System
California
$35.1M -$1.45M -14,060 -4%
State Farm Mutual Automobile Insurance
68
State Farm Mutual Automobile Insurance
Illinois
$34.8M
RA
69
Royce & Associates
New York
$34.4M +$1.21M +11,712 +4%
Lord, Abbett & Co
70
Lord, Abbett & Co
New Jersey
$33.2M -$8.09M -78,388 -20%
PM
71
Pembroke Management
Quebec, Canada
$33M +$779K +7,548 +3%
RhumbLine Advisers
72
RhumbLine Advisers
Massachusetts
$32.1M +$311K +3,016 +1%
Loomis, Sayles & Company
73
Loomis, Sayles & Company
Massachusetts
$31.9M -$739K -7,164 -2%
Goldman Sachs
74
Goldman Sachs
New York
$30M -$23.2M -224,820 -45%
California State Teachers Retirement System (CalSTRS)
75
California State Teachers Retirement System (CalSTRS)
California
$28.3M -$1.56M -15,088 -5%

TECH Hedge Fund Activity: Q1 2022 in Review

556 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2022, worth a combined $16.2B — down 15% from $19.1B a quarter earlier.

Sellers outnumbered buyers: 76 funds closed out of TECH and 65 opened new positions — a net loss of 11 holders — while 209 trimmed existing stakes and 199 added.

The largest buyer was Select Equity Group, opening a new position worth an estimated $288M. The largest seller was Marshall Wace, cutting an estimated $125M.

  • 556 institutional investors held Bio-Techne (TECH) as of Q1 2022, down from 575 in Q4 2021.
  • Funds reported $16.2B of Bio-Techne stock for Q1 2022, down 15% quarter-over-quarter.
  • 65 funds opened new Bio-Techne positions in Q1 2022 and 76 closed out, a net change of -11 holders.
  • The largest Bio-Techne buyer in Q1 2022 was Select Equity Group, an estimated $288M added.
  • The largest Bio-Techne seller in Q1 2022 was Marshall Wace, an estimated $125M sold.

Based on aggregated 13F filings for Q1 2022.